Basic Information
| LncRNA/CircRNA Name | XLOC_006390 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | PCR, Western blot, RIP |
| Sample | PC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | XLOC_006390/c-Myc may be a potential target for PC, and its abnormal activation also indicates the progression of PC. |
| Pubmed ID | 31734356 |
| Year | 2019 |
| Title | LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc |
External Links
| Links for XLOC_006390 | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |